Literature DB >> 1382312

Modulation of the dimerization of a transcriptional antiterminator protein by phosphorylation.

O Amster-Choder1, A Wright.   

Abstract

The transcriptional antiterminator protein BglG inhibits transcription termination of the bgl operon in Escherichia coli when it is in the nonphosphorylated state. The BglG protein is now shown to exist in two configurations, an active, dimeric nonphosphorylated form and an inactive, monomeric phosphorylated form. The migration of BglG on native polyacrylamide gels was consistent with it existing as a dimer when nonphosphorylated and as a monomer when phosphorylated. Only the nonphosphorylated dimer was found to bind to the target RNA. When the dimerization domain of the lambda repressor was replaced with BglG, the resulting chimera behaved like an intact lambda repressor in its ability to repress lambda gene expression, which suggests that BglG dimerizes in vivo. Repression by the lambda-BglG hybrid was significantly reduced by BglF, the BglG kinase, an effect that was relieved by conditions that stimulate dephosphorylation of BglG by BglF. These results suggest that the phosphorylation and the dephosphorylation of BglG regulate its activity by controlling its dimeric state.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1382312     DOI: 10.1126/science.1382312

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  41 in total

1.  Genetic selection for dissociative inhibitors of designated protein-protein interactions.

Authors:  S H Park; R T Raines
Journal:  Nat Biotechnol       Date:  2000-08       Impact factor: 54.908

2.  Mu and IS1 transpositions exhibit strong orientation bias at the Escherichia coli bgl locus.

Authors:  D Manna; X Wang; N P Higgins
Journal:  J Bacteriol       Date:  2001-06       Impact factor: 3.490

3.  Crystal structure of an activated form of the PTS regulation domain from the LicT transcriptional antiterminator.

Authors:  H van Tilbeurgh; D Le Coq; N Declerck
Journal:  EMBO J       Date:  2001-07-16       Impact factor: 11.598

4.  Mutations that activate the silent bgl operon of Escherichia coli confer a growth advantage in stationary phase.

Authors:  Ranjna Madan; Roberto Kolter; S Mahadevan
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

5.  Evidence that the Bacillus subtilis pyrimidine regulatory protein PyrR acts by binding to pyr mRNA at three sites in vivo.

Authors:  Y Lu; R L Switzer
Journal:  J Bacteriol       Date:  1996-10       Impact factor: 3.490

6.  A mutation in a new gene, bglJ, activates the bgl operon in Escherichia coli K-12.

Authors:  M Giel; M Desnoyer; J Lopilato
Journal:  Genetics       Date:  1996-06       Impact factor: 4.562

7.  Transcription antitermination regulation of the Pseudomonas aeruginosa amidase operon.

Authors:  S A Wilson; S J Wachira; R A Norman; L H Pearl; R E Drew
Journal:  EMBO J       Date:  1996-11-01       Impact factor: 11.598

8.  From genetic to structural characterization of a new class of RNA-binding domain within the SacY/BglG family of antiterminator proteins.

Authors:  X Manival; Y Yang; M P Strub; M Kochoyan; M Steinmetz; S Aymerich
Journal:  EMBO J       Date:  1997-08-15       Impact factor: 11.598

9.  In vivo expression of the beta-glucoside (bgl) operon of Escherichia coli occurs in mouse liver.

Authors:  M A Khan; R E Isaacson
Journal:  J Bacteriol       Date:  1998-09       Impact factor: 3.490

10.  An antiestrogen: a phosphotyrosyl peptide that blocks dimerization of the human estrogen receptor.

Authors:  S F Arnold; A C Notides
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.